Neuberger Berman Group LLC Bluebird Bio, Inc. Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$59.1 - $93.26 $425,460 - $671,378	-7,199 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $88,060 - $116,432	991 Added 15.96%	7,199 $1.05 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $147,267 - $188,578	1,478 Added 31.25%	6,208 $974,000
Q1 2018 May 08, 2018	SELL	$105.8 - $150.94 $10.8 Million - $15.3 Million	-101,631 Reduced 95.55%	4,730 $808,000
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $8.64 Million - $13.9 Million	106,361	106,361 $18.9 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $29.3M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.